At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.
Patent # | Description |
---|---|
2017/0143802 |
COMPOSITION FOR TREATING DIABETES COMPRISING LONG-ACTING INSULIN ANALOGUE
CONJUGATE AND LONG-ACTING... The present invention relates to a composition for the prevention or treatment of diabetes including a long-acting insulin conjugate and a long-acting... |
2017/0143801 |
Pharmaceutical Combination for Use in Glycemic Control in Diabetes Type 2
Patients The present invention refers to a pharmaceutical combination for use in glycemic control in diabetes type 2 patients. |
2017/0143800 |
Calcitonin Mimetics for Treating Diseases and Disorders Calcitonin mimetic peptides having an amino acid sequence in accordance with SEQ ID NO:8 or SEQ ID NO:53, each of which may be carboxylated at its N-terminal... |
2017/0143799 |
Methods and Compositions for Treatment of Conditions Associated with
Elevated Triglycerides Methods and compositions for reducing one or more of triglyceride levels, total cholesterol levels and LDL cholesterol levels in a subject are provided. The... |
2017/0143798 |
MODULATION OF CELLULAR STRESS Disclosed are compositions and methods for modulating oxidative and/or endoplasmic reticulum (OER) stress. More particularly, the present invention discloses... |
2017/0143797 |
Vault Complexes for Cytokine Delivery The invention relates to compositions of vault complexes containing recombinant cytokine fusion proteins that include a cytokine and a vault targeting domain,... |
2017/0143796 |
ENGINEERED NUCLEIC ACIDS AND METHODS OF USE THEREOF Provided are compositions and methods for delivering biological moieties such as modified nucleic acids into cells to modulate protein expression. Such... |
2017/0143795 |
bFGF-POLYMER CONJUGATES, METHODS FOR MAKING THE SAME AND APPLICATIONS
THEREOF A heparin mimicking polymer, its conjugate with bFGF, and method of making and using the same are disclosed. In particular, described herein are conjugates of... |
2017/0143794 |
Treatment of Allodynia, Hyperalgsia, Spontaneous Pain, and Phantom Pain The present invention relates to use of Cometin in a method of treatment of allodynia, hyperalgesia, spontaneous pain and/or phantom pain. In a preferred... |
2017/0143793 |
SWEET TASTE RECEPTOR ANTAGONIST COMPOSITIONS The present disclosure relates to compositions comprising gymnemic acid, together with a form of zinc to block the unpleasant bitter taste of gymnemic acid as... |
2017/0143792 |
CYCLOSPORIN COMPOSITIONS Disclosed herein are therapeutic methods, compositions, and medicaments related to cyclosporine. |
2017/0143791 |
OCTREOTIDE DEPOT FORMULATION WITH CONSTANTLY HIGH EXPOSURE LEVELS The present invention relates to sustained release formulations comprising as active ingredient octreotide or a pharmaceutically-acceptable salt thereof and... |
2017/0143790 |
OXYTOCIN IMPROVES TREATMENT OF OBSTRUCTIVE SLEEP APNEA The present disclosure provides methods for treating obstructive sleep apnea (OSA) and OSA induced cardiorespiratory diseases. The disclosure provides, inter... |
2017/0143789 |
AGONISTS OF GUANYLATE CYCLASE AND THEIR USES This invention provides a method of colonic cleansing. |
2017/0143788 |
COMPOSITIONS AND METHODS FOR AFFECTING MOVEMENT OF CONTAMINANTS, BODILY
FLUIDS OR OTHER ENTITIES, AND/OR... Compositions which self-assemble under physiological conditions are formulated for application to wounds. The formulations include a pharmaceutically... |
2017/0143787 |
CHEMOKINE RECEPTOR ANTAGONIST AND ITS COMBINATIONAL THERAPY A method for treating various types of cancer/tumor by administering the combination of SDF-1 antagonist, in particular, that specifically binds to human... |
2017/0143786 |
INTRAVAGINAL FORMULATIONS COMPRISING GnRH An intravaginal formulation is provided, comprising a carboxylic acid in a n amount of 10-20% w/w of said formulation, an oleaginous base, having melting... |
2017/0143785 |
PEPTIDE AS ABSORPTION ENHANCER AND COMPOSITION CONTAINING SAME The present invention modifies the carboxyl-terminal end of a peptide used as a permeation enhancer to enhance the function of the peptide to boost the mucous... |
2017/0143784 |
MITOCHONDRIAL-TARGETED ANTIOXIDANTS PROTECT AGAINST MECHANICAL
VENTILATION-INDUCED DIAPHRAGM DYSFUNCTION AND... The present disclosure provides methods and compositions for preventing or treating MV-induced or disuse-induced skeletal muscle infirmities in a mammalian... |
2017/0143783 |
SOLID FORMULATION AND METHOD FOR PREVENTING OR REDUCING COLORATION THEREOF The present invention relates to stabilization of a certain benzothia(dia)zepine derivative in a solid formulation containing the same. In the present... |
2017/0143782 |
EXTRACTS AND ISOLATED COMPOUNDS FROM CAKILE ARABICA FOR TREATMENT OF ULCER The present invention relates to extracts, compounds isolated from Cakile arabica for use in the treatment of ulcer and to pharmaceutical compositions thereof. |
2017/0143781 |
PAIN RELIEF COMPOSITION Natural pain relief and muscle recovery compositions having a wide variety of topical applications are provided. In certain embodiments, the pain relief... |
2017/0143780 |
COMBINATION OF ONCOLYTIC VIRUS WITH IMMUNE CHECKPOINT MODULATORS The present invention provides a combination comprising at least an oncolytic virus and one or more immune checkpoint modulator(s) for use for the treatment of... |
2017/0143779 |
AAV Mediated Exendin-4 Gene Transfer to Salivary Glands to Protect
Subjects from Diabetes or Obesity The invention relates to a gene transfer-based method to protect a subject from diabetes or obesity. The method comprises administering to a salivary gland of... |
2017/0143778 |
A METHOD OF FEEDING AN ANIMAL TO IMPROVE GROWTH EFFICIENCY The present invention relates to a method of feeding an animal to improve growth efficiency. |
2017/0143777 |
COMPOSITIONS COMPRISING PROBIOTICS AND METHODS OF USE THEREOF The present invention provides compositions comprising a probiotc in admixture with an effective amount of an amphipathic substance that enhances viability of... |
2017/0143776 |
FORMULATION AND TREATMENT FOR ACNE The present invention relates to composition comprising Lactobacillus rye ferment, dialkylisosorbide and phospholipid. Preferably, the composition further... |
2017/0143775 |
COMPOSITIONS COMPRISING BACTERIAL STRAINS The invention provides compositions comprising bacterial strains for treating and preventing inflammatory and autoimmune diseases. |
2017/0143774 |
COMPOSITIONS COMPRISING BACTERIAL STRAINS The invention provides compositions comprising bacterial strains for treating and preventing inflammatory and autoimmune diseases. |
2017/0143773 |
COMPOSITIONS COMPRISING BACTERIAL STRAINS The invention provides compositions comprising bacterial strains for treating and preventing inflammatory and autoimmune diseases. |
2017/0143772 |
COMPOSITIONS COMPRISING BACTERIAL STRAINS The invention provides compositions comprising bacterial strains for treating and preventing cancer. |
2017/0143771 |
COMPOSITION CONTAINING PSEUDOMONAS AERUGINOSA CULTURE SOLUTION EXTRACT
HAVING ANTIBIOTIC AND ANTISEPTIC... The present invention provides an antiseptic and antibiotic composition containing a Pseudomonas aeruginosa culture solution extract as an active ingredient.... |
2017/0143770 |
SOFT TISSUE REPAIR AND REGENERATION USING POSTPARTUM-DERIVED CELLS AND
CELL PRODUCTS Cells derived from postpartum tissue and products thereof having the potential to support cells of and/or differentiate to cells of a soft tissue lineage, and... |
2017/0143769 |
HUMAN UMBILICAL CORD BLOOD-DERIVED MONOCYTES FOR TREATMENT OF
NEURODEGENERATIVE DISEASES AND DISORDERS Human umbilical cord blood-derived monocytes that markedly promote A.beta. clearance through heterodimerization of sAPP.alpha. with A.beta. and resultant... |
2017/0143768 |
OINTMENT FOR THE TREATMENT OF HEMORRHOIDAL DISEASE An ointment for the treatment of internal hemorrhoids, able to avoid the advanced stages of the disease and the need for surgical intervention on long term.... |
2017/0143766 |
STEM CELL SUBPOPULATIONS WITH DIFFERENTIAL GSTT1 EXPRESSION OR GENOTYPE A method for providing a sub-population of stem cell or plurality of stem cells by determining or modulating GSTT1 expression level or genotype is disclosed... |
2017/0143765 |
CHIMERIC ANTIGEN RECEPTOR AND METHODS OF USE THEREOF The present disclosure provides a heterodimeric, conditionally active chimeric antigen receptor (CAR), and a nucleic acid comprising a nucleotide sequence... |
2017/0143764 |
MENSTRUAL BLOOD-DERIVED STEM CELLS FOR THE TREATMENT OF HUMAN PANCREATIC
CARCINOMA A method and compound product are created from menstrual blood-derived mesenchymal stem cells (MenSCs) with an anti-tumor effect. In particular, the method and... |
2017/0143763 |
ORALLY ADMINISTERED ADSORBENT, THERAPEUTIC AGENT FOR RENAL DISEASE, AND
THERAPEUTIC AGENT FOR LIVER DISEASE An object of the present invention is to provide an orally administered adsorbent capable of adsorbing large quantities of tryptophan or indoxyl sulfate in the... |
2017/0143762 |
GRAPHENE AND GRAPHENE-RELATED MATERIALS FOR MANIPULATION OF CELL MEMBRANE
POTENTIAL Structures based on graphene-related materials, methods for their preparation, and methods for their use are disclosed. These structures can be utilized for... |
2017/0143761 |
METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH INFECTION
AND/OR INFLAMMATION The present invention provides methods and compositions for treating and preventing conditions characterized by infection and/or inflammation, especially of... |
2017/0143760 |
UNIVERSAL CARDIOPLEGIC SOLUTION (VARIANTS) This invention relates to medicine, more specifically, to cardiac surgery, and may be used for protecting the heart from ischemia when administering... |
2017/0143759 |
PHARMACEUTICAL FORMULATIONS OF NITRITE AND USES THEREOF The present invention relates to pharmaceutical compositions of nitrites such as inorganic nitrites, or any pharmaceutically acceptable salts, solvates, or... |
2017/0143758 |
INHALATION OF NITRIC OXIDE FOR TREATING RESPIRATORY DISEASES A method of treating a human subject which is effected by intermittent inhalation of gaseous nitric oxide at a concentration of at least 160 ppm is disclosed.... |
2017/0143757 |
MANDELIC ACID CONDENSATION POLYMERS Disclosed herein are compounds and compositions useful for reducing the risk of infection. In particular, disclosed herein are mandelic acid condensation... |
2017/0143756 |
Antitumor Composition Based on Hyaluronic Acid and Inorganic
Nanoparticles, Method of Preparation Thereof and... The invention relates to an antitumor composition based on hydrophobized hyaluronan and inorganic nanoparticles stabilized by oleic acid. The hydrophobized... |
2017/0143755 |
CHITOSAN DERIVATIVES FOR INACTIVATION OF ENDOTOXINS AND SURFACE PROTECTION
OF NANOPARTICLES The present disclosure provides a polymer comprising a derivative of chitosan, wherein the derivative is zwitterionic, as well as methods of using the polymer.... |
2017/0143754 |
Dendritic Cell Immune Receptor Activator, Method for Activating Dendritic
Cell Immune Receptor, Osteoclast... A dendritic cell immune receptor activator, comprising a compound having a sugar chain as an active ingredient, the sugar chain having a basic structure... |
2017/0143753 |
SOPHOROLIPID ESTER CHAIN LENGTH DEPENDENCE ON THE INHIBITION OF HUMAN
PATHOGENS A method for inhibitory and bactericidal activities against human pathogens by n-alkyl chain length of modified sophorolipid n-alkyl esters, and preferred... |
2017/0143752 |
METHOD AND COMPOSITIONS FOR TREATING CHRONIC INFLAMMATORY DISORDERS A method and composition for treating chronic inflammatory disorders comprising a pharmaceutically acceptable carrier suitable for oral administration or... |